Immuneering (IMRX) Receivables - Net: 2020-2023
Historic Receivables - Net for Immuneering (IMRX) over the last 2 years, with Mar 2023 value amounting to $1,046.
- Immuneering's Receivables - Net fell 99.63% to $1,046 in Q1 2023 from the same period last year, while for Mar 2023 it was $1,046, marking a year-over-year decrease of 99.63%. This contributed to the annual value of $12,417 for FY2022, which is 94.95% down from last year.
- Latest data reveals that Immuneering reported Receivables - Net of $1,046 as of Q1 2023, which was down 91.58% from $12,417 recorded in Q4 2022.
- Immuneering's 5-year Receivables - Net high stood at $500,110 for Q4 2020, and its period low was $1,046 during Q1 2023.
- Over the past 3 years, Immuneering's median Receivables - Net value was $212,232 (recorded in 2021), while the average stood at $219,275.
- Data for Immuneering's Receivables - Net shows a maximum YoY plummeted of 99.63% (in 2023) over the last 5 years.
- Quarterly analysis of 4 years shows Immuneering's Receivables - Net stood at $500,110 in 2020, then crashed by 50.80% to $246,040 in 2021, then crashed by 94.95% to $12,417 in 2022, then plummeted by 99.63% to $1,046 in 2023.
- Its Receivables - Net was $1,046 in Q1 2023, compared to $12,417 in Q4 2022 and $70,180 in Q3 2022.